Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Long-Term Safety Study of BHV-3000 in the Acute Treatment of Migraine

NCT03266588 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03266588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03266588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Long-Term Safety Study of BHV-3000 in the Acute Treatment of Migraine
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
August 30, 2017
Completion date
July 15, 2019
Enrollment
3,019 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, with or without aura